Fate Therapeutics, Inc. - Common Stock (NQ: FATE )
1.255
+0.005
(+0.40%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 14, 2025
Add to My Watchlist
All News about Fate Therapeutics, Inc. - Common Stock
Fate Therapeutics Initiated With Hold Rating - Read Why
July 28, 2022
Via Benzinga
Fate Therapeutics to Present at Upcoming Investor Conferences
November 04, 2022
Via GlobeNewswire
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|